Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100041986Phase 4Recruiting
Phase 4, randomised trial of remimazolam in genitourinary diseases (GU) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Postoperative quality of recovery score. Started Feb 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100041986.